Dishman Carbogen Amcis Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DCAL.NS | 688166.SS | 3759.HK | 060590.KQ | 300204.SZ | 603229.SS | |
|---|---|---|---|---|---|---|
| Market cap | 24.70B | 13.81B | 55.85B | 63.96B | 9.74B | 6.06B |
| P/E (TTM) | 152.9 | 132.1 | 27.4 | — | — | — |
| Forward P/E | 12.6 | 53.7 | 17.2 | — | 23.4 | 17.4 |
| Price/book | 0.4 | 4.5 | 2.8 | — | 4.6 | 2.6 |
| Dividend yield | — | 0.05% | 0.78% | — | — | 0.89% |
| 1-year change | −42.20% | −44.06% | +19.72% | −47.01% | −53.34% | −28.06% |
| Today | +1.75% | +2.42% | +3.47% | +2.49% | +3.75% | +1.67% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All DCAL.NS news ›Beta Drugs vs Dishman Carbogen Amcis vs Fredun Pharmaceuticals
Beta Drugs PE 45.47, mkt cap Rs 2,104 crore. Dishman Carbogen Amcis PE 142.48, mkt cap Rs 2,301 crore. Fredun Pharmaceuticals PE 57.90, mkt cap Rs 2,537 crore. Beta Drugs vs Dishman Carbogen Amcis vs Fredun Pharmaceuticals starts with the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- univest.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.